RBC Capital Maintains Outperform on AdaptHealth, Raises Price Target to $15
ADAPTHEALTH CORP
ADAPTHEALTH CORP AHCO | 0.00 |
RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ:
AHCO) with a Outperform and raises the price target from $13 to $15.
